Results 81 to 90 of about 170,196 (315)

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

Optimizing pharmacogenomic clinical decision support: a usability study of epic’s Genomic-Indicators

BMC Pharmacology and Toxicology
Background Pharmacogenomic (PGx)-guided therapy has demonstrated improved medication-related outcomes and reduced healthcare costs. Interruptive clinical decision support (CDS) alerts are crucial in providing guidance to providers in PGx-informed ...
Je-Won J. Hong, Bradley T. Hall, Syed Azeem, Dean A. Jacobs, Grace C. Hogan, Madeline L. Norris, Emily J. Cicali, Julio D. Duarte, Larisa H. Cavallari, Khoa A. Nguyen   +9 more
doaj   +1 more source

Pharmacotherapy of Parkinson`s disease

, 2016
There are several drugs which are effective in symptomatic management of Parkinson`s disease However there is no definitive pharmaceutical therapy for Parkinson`s disease. Drugs used in symptomatic management of Parkinson`s disease include : dopaminergic
Mohammad ali, Bahmaei
core  

Pharmacotherapy of insomnia in older adults

, 2023
Independently from age related changes, sleep problems affect 10-15% of the general population and increase with older age as well. Insomnia is the most prevalent and the most researched sleep disturbance.
Petrovic, MirkoGE358010018454810000-0002-7506-8646F7148516-F0ED-11E1-A9DE-61C894A0A6B4, Mangoni, Arduinoeditor, Petrovic, MirkoeditorGE358010018454810000-0002-7506-8646F7148516-F0ED-11E1-A9DE-61C894A0A6B4, Cherubini, Antonioeditor, O'Mahony, Deniseditor   +4 more
core  

Fostering medication review competence of pharmacy students: An assessment by students and their preceptors after advanced‐level practical internship

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman, Aleksi Westerholm, Tero Vahlberg, Noora Lias, Tanja Lindholm, Marja Airaksinen   +5 more
wiley   +1 more source

Pharmacotherapy of panic disorder

, 2008
Charles B Pull1, Cristian Damsa21Department of Neurosciences, Centre Hospitalier de Luxembourg, Luxembourg; 2Department of Psychiatry, Clinical Investigation Program, University of Colorado Health Sciences Center, USAAbstract: Panic disorder (PD) is a ...
Pull, Charles B., Cristian Damsa, Damsa, Cristian, Charles B Pull   +3 more
core  

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

Plasma Melanin-Concentrating Hormone in Childhood Obesity and Its Association with Metabolic Parameters: A Clinical Observational Study

Diabetes, Metabolic Syndrome and Obesity
Imre Leiter,1,&ast; Beáta Lelesz,1,&ast; Csaba Heged&udblac;s,1 József Németh,1 Beáta Pelles-Taskó,1 Gyula Ujlaki,1 Harjit Pal Bhattoa,2 Enik&odblac; Noémi Felszeghy,3 Szabolcs Lengyel,4 Dénes Páll,4 György Balla,3 Zoltán Szilvássy,1 Béla
Leiter I, Lelesz B, Hegedűs C, Németh J, Pelles-Taskó B, Ujlaki G, Bhattoa HP, Felszeghy EN, Lengyel S, Páll D, Balla G, Szilvássy Z, Juhász B, Kiss R   +13 more
doaj  

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Impact of a genetic counseling requirement prior to genetic testing

BMC Health Services Research, 2018
Background Genetic counseling by a Genetic Counselor (GC) is a requirement prior to genetic testing for cancer susceptibility genes (GC-mandate policy) for some insurers.
David D. Stenehjem, Trang Au, Amy M. Sainski, Hillevi Bauer, Krystal Brown, Johnathan Lancaster, Vanessa Stevens, Diana I. Brixner   +7 more
doaj   +1 more source